XML 60 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Cash flows from operating activities:    
Net income $ 302,366 $ 308,766
Adjustments to reconcile net income to net cash flows from operating activities:    
Depreciation and amortization 83,945 92,545
Share-based compensation 32,396 33,119
Deferred income taxes (3,876) 71,974
Other (29,073) (19,689)
Changes in operating assets and liabilities, net:    
Accounts receivable (89,066) (90,712)
Accrued expenses and other current liabilities (82,031) (149,063)
Other changes in operating assets and liabilities, net (20,036) 6,638
Net cash flows provided by operating activities 194,625 253,578
Cash flows from investing activities:    
Proceeds from sales and maturities of marketable securities 824,434 788,083
Purchases of marketable securities (677,092) (908,730)
Acquisition of Stromedix, Inc., net of cash acquired (72,401)  
Purchases of property, plant and equipment (54,551) (32,143)
Other (19,772) 25,995
Net cash flows provided by (used in) investing activities 618 (126,795)
Cash flows from financing activities:    
Purchase of treasury stock (463,171) (195,287)
Proceeds from issuance of stock for share-based compensation arrangements 24,080 91,155
Other 22,827 4,300
Net cash flows used in financing activities (416,264) (99,832)
Net (decrease) increase in cash and cash equivalents (221,021) 26,951
Effect of exchange rate changes on cash and cash equivalents 4,618 4,126
Cash and cash equivalents, beginning of the period 514,542 759,598
Cash and cash equivalents, end of the period $ 298,139 $ 790,675